Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · Gynaecology and Fertility

No studies found 1 · 25%GRADE not reported 0 · 0%Very low 3 · 75%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Adverse events ‐ Miscarriage · subfertile women with polycystic ovary syndrome

It is very uncertain whether myo‐inositol changes adverse event ‐ miscarriage compared with D‐chiro‐inositol (very low certainty).

1 finding from 1 review

Inositol for subfertile women with polycystic ovary syndrome 2018 · Cochrane Headline outcomes only
OR 1.3 [0.27, 6.2]
1 study · 84 participants
Very low

Adverse events ‐ Miscarriage · subfertile women with polycystic ovary syndrome

It is very uncertain whether myo‐inositol changes adverse event ‐ miscarriage compared with placebo, no/standard treatment (very low certainty).

1 finding from 1 review

Inositol for subfertile women with polycystic ovary syndrome 2018 · Cochrane Headline outcomes only
OR 0.4 [0.19, 0.86]
4 studies · 535 participants
Very low

Adverse events ‐ Miscarriage · subfertile women with polycystic ovary syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Inositol for subfertile women with polycystic ovary syndrome 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adverse events ‐ Miscarriage · subfertile women with polycystic ovary syndrome

It is very uncertain whether myo‐inositol changes adverse event ‐ miscarriage compared with antioxidant (melatonin) (very low certainty).

1 finding from 1 review

Inositol for subfertile women with polycystic ovary syndrome 2018 · Cochrane Headline outcomes only
OR 0.7 [0.22, 2.24]
1 study · 358 participants
Very low